Grant: Team Grant: Cannabis Research in Priority Areas - Neurodevelopment
University of Alberta
$1,499,915.00
Maternal-infant dyad health outcomes: infant neurodevelopment in the context of maternal cannabis use - a prospective cohort study
FY 2019-20
Summary
In October 2018, recreational cannabis became legal in Canada; before then medical use was legal. Babies are exposed to cannabis their mothers use during pregnancy and through breastmilk. Research-informed information for parents and families is scarce and pregnant women receive mixed messages around the safety of cannabis. The Canadian government recommends avoiding it since there is no known safe level to use during pregnancy. Exposures have a higher risk of causing permanent health changes in growing and developing babies. Long term outcomes of cannabis exposure are not known. Some teens who use cannabis have permanent brain changes and an increased risk of mental health problems. Much less is known about second-hand cannabis exposure, especially in young children. We do not know whether cannabis smoke exposes children to biologically significant levels of cannabis.
This study will follow women from early pregnancy until their babies are 18 months old. Mothers will report if, when and how they use cannabis. Their sleep, activity, mental and physical health and the baby's birth, development, behavior and health will be monitored, including a formal assessment at 18 months. The family will use an air quality monitor and passive environmental samplers for mothers and babies. They will also complete an environmental assessment. Breastmilk and urine will be tested for cannabis to see if babies absorb cannabis used by mothers. Passive sampler analyses will provide evidence of other exposures that could confuse the picture, like tobacco smoke and air pollution. Sleep and mood are related and impact development, so maternal and infant sleep will be monitored. Cannabis, used medically and for recreation, presents potential risks and benefits to expectant mothers and families. This study will provide valuable information to help families make informed choices about cannabis and set the stage for future research on the long term effects of cannabis exposure on children.
Department
Program
Team Grant: Cannabis Research in Priority Areas - Neurodevelopment
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
418187
Name
Hicks Matthew S
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Clinical
Prcname2
Team Grant: Cannabis Research in Priority Areas
Projecttitle
Maternal-infant dyad health outcomes: infant neurodevelopment in the context of maternal cannabis use - a prospective cohort study
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$1,499,915
Cihrequipment2
$0
Programname2
Team Grant: Cannabis Research in Priority Areas - Neurodevelopment
Keyworddelim
Biomarkers; Cannabis Metabolites In Breast Milk; Cohort Study; Environmental Exposures; Maternal Cannabis Use; Maternal Mental Health; Neurodevelopment; Sleep
Abstract
In October 2018, recreational cannabis became legal in Canada; before then medical use was legal. Babies are exposed to cannabis their mothers use during pregnancy and through breastmilk. Research-informed information for parents and families is scarce and pregnant women receive mixed messages around the safety of cannabis. The Canadian government recommends avoiding it since there is no known safe level to use during pregnancy. Exposures have a higher risk of causing permanent health changes in growing and developing babies. Long term outcomes of cannabis exposure are not known. Some teens who use cannabis have permanent brain changes and an increased risk of mental health problems. Much less is known about second-hand cannabis exposure, especially in young children. We do not know whether cannabis smoke exposes children to biologically significant levels of cannabis.
This study will follow women from early pregnancy until their babies are 18 months old. Mothers will report if, when and how they use cannabis. Their sleep, activity, mental and physical health and the baby's birth, development, behavior and health will be monitored, including a formal assessment at 18 months. The family will use an air quality monitor and passive environmental samplers for mothers and babies. They will also complete an environmental assessment. Breastmilk and urine will be tested for cannabis to see if babies absorb cannabis used by mothers. Passive sampler analyses will provide evidence of other exposures that could confuse the picture, like tobacco smoke and air pollution. Sleep and mood are related and impact development, so maternal and infant sleep will be monitored. Cannabis, used medically and for recreation, presents potential risks and benefits to expectant mothers and families. This study will provide valuable information to help families make informed choices about cannabis and set the stage for future research on the long term effects of cannabis exposure on children.
Competitiondate
201910
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Hicks, Matthew S; Sikora, Christopher; Hicks, Elizabeth A
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $1,499,915~ $0~